Trial Profile
A Phase 2 trial of IO102 for melanoma treatment
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 18 Oct 2017
Price :
$35
*
At a glance
- Drugs IO 102 (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 18 Oct 2017 New trial record